|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000100650 |
Summary for SRSF5 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000100650 | Gene symbol | SRSF5 |
| Gene name | serine and arginine rich splicing factor 5 | |
| HGNC | 10787 | |
| Entrez ID | 6430 | |
| Gene type | protein_coding | |
| Synonyms | SRSF5|SRP40|HRS | |
| UniProtAcc | Q13243 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for SRSF5 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| SRSF5 | 6.54e+03 | -1.01e+00 | 1.93e-01 | -5.24e+00 | 1.63e-07 | 1.40e-06 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for SRSF5 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for SRSF5 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| ACC | cg12848614 | chr14:69726779 | CGI:chr14:69726750-69727238 | promoter | 1.78e-01 | 2.86e-01 | -2.76e+00 | 5.76e-03 | 1.87e-02 | -1.08e-01 |
| CHOL | cg12848614 | chr14:69726779 | CGI:chr14:69726750-69727238 | promoter | 2.36e-01 | 9.25e-02 | 2.26e+00 | 2.38e-02 | 3.61e-02 | 1.44e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg12848614 | chr14:69726779 | CGI:chr14:69726750-69727238 | promoter | 1.19e-01 | 2.73e-01 | -4.55e+00 | 5.45e-06 | 7.44e-05 | -1.54e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg12848614 | chr14:69726779 | CGI:chr14:69726750-69727238 | promoter | 2.21e-01 | 1.14e-01 | 5.23e+00 | 1.66e-07 | 3.32e-07 | 1.07e-01 |
Top |
Exon skipping events with PSI in TCGA for SRSF5 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for SRSF5 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for SRSF5 |
TFs related to SRSF5.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| THYM | ZNF418 | SRSF5 | 4.85e+00 | 1.27e-02 | 5.49e+00 | 9.85e-01 | Female-biased |
SRSF5 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for SRSF5 |
RBPs related to ES in SRSF5.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | PABPC5 | exon_skip_107751 | 6.92e+00 | 3.46e-03 | 7.38e+00 | 9.86e-01 | Female-biased |
| STAD | RBM3 | exon_skip_107755 | 1.14e+01 | 5.71e-03 | 1.18e+01 | 9.94e-01 | Female-biased |
| STAD | STAR-PAP | exon_skip_107751 | 1.36e+01 | 2.31e-04 | 1.44e+01 | 1.00e+00 | Female-biased |
| ACC | PABPC5 | exon_skip_107753 | 9.00e+00 | 2.81e-03 | 9.56e+00 | 9.94e-01 | Female-biased |
| ACC | STAR-PAP | exon_skip_107749 | 1.64e+01 | 9.99e-01 | 1.57e+01 | 1.48e-03 | Male-biased |
| ACC | STAR-PAP | exon_skip_107751 | 1.38e+01 | 1.06e-03 | 1.45e+01 | 9.99e-01 | Female-biased |
| UVM | PABPC5 | exon_skip_107753 | 9.33e+00 | 8.11e-03 | 9.64e+00 | 9.89e-01 | Female-biased |
| UVM | STAR-PAP | exon_skip_107749 | 1.62e+01 | 2.70e-04 | 1.68e+01 | 1.00e+00 | Female-biased |
| THYM | HNRNPA1L2 | exon_skip_107755 | 7.17e+00 | 5.31e-03 | 7.54e+00 | 9.84e-01 | Female-biased |
| THYM | RBM3 | exon_skip_107755 | 1.13e+01 | 1.79e-03 | 1.18e+01 | 9.98e-01 | Female-biased |
| THYM | STAR-PAP | exon_skip_107749 | 1.61e+01 | 1.26e-04 | 1.68e+01 | 1.00e+00 | Female-biased |
| COAD | STAR-PAP | exon_skip_107751 | 1.46e+01 | 9.99e-01 | 1.41e+01 | 1.17e-03 | Male-biased |
| DLBC | STAR-PAP | exon_skip_107749 | 1.70e+01 | 1.00e+00 | 1.62e+01 | 3.72e-04 | Male-biased |
| DLBC | STAR-PAP | exon_skip_107751 | 1.44e+01 | 2.94e-04 | 1.51e+01 | 1.00e+00 | Female-biased |
| KIRP | STAR-PAP | exon_skip_107749 | 1.60e+01 | 3.74e-04 | 1.66e+01 | 1.00e+00 | Female-biased |
| BRCA | STAR-PAP | exon_skip_107749 | 1.61e+01 | 9.86e-01 | 1.55e+01 | 1.44e-02 | Male-biased |
| BRCA | STAR-PAP | exon_skip_107751 | 1.42e+01 | 9.90e-01 | 1.36e+01 | 9.36e-03 | Male-biased |
| ESCA | RBM3 | exon_skip_107755 | 1.11e+01 | 1.40e-02 | 1.15e+01 | 9.85e-01 | Female-biased |
| ESCA | STAR-PAP | exon_skip_107751 | 1.37e+01 | 1.63e-03 | 1.44e+01 | 9.98e-01 | Female-biased |
| READ | RBM3 | exon_skip_107755 | 1.11e+01 | 4.49e-03 | 1.15e+01 | 9.95e-01 | Female-biased |
| READ | STAR-PAP | exon_skip_107749 | 1.56e+01 | 3.01e-04 | 1.62e+01 | 1.00e+00 | Female-biased |
| READ | STAR-PAP | exon_skip_107751 | 1.43e+01 | 9.99e-01 | 1.37e+01 | 7.40e-04 | Male-biased |
| PCPG | ELAVL2 | exon_skip_107763 | 6.89e+00 | 9.81e-01 | 6.50e+00 | 4.61e-03 | Male-biased |
| PCPG | RBM3 | exon_skip_107755 | 1.11e+01 | 1.35e-03 | 1.16e+01 | 9.98e-01 | Female-biased |
| PCPG | SFPQ | exon_skip_107755 | 7.39e+00 | 2.23e-03 | 7.84e+00 | 9.89e-01 | Female-biased |
| MESO | RBM3 | exon_skip_107755 | 1.13e+01 | 2.72e-03 | 1.17e+01 | 9.97e-01 | Female-biased |
| MESO | STAR-PAP | exon_skip_107749 | 1.57e+01 | 4.55e-04 | 1.64e+01 | 1.00e+00 | Female-biased |
| GBM | PABPC5 | exon_skip_107751 | 7.11e+00 | 7.94e-03 | 7.47e+00 | 9.81e-01 | Female-biased |
| GBM | STAR-PAP | exon_skip_107749 | 1.56e+01 | 5.84e-04 | 1.62e+01 | 9.99e-01 | Female-biased |
| GBM | STAR-PAP | exon_skip_107751 | 1.38e+01 | 6.59e-04 | 1.44e+01 | 9.99e-01 | Female-biased |
| PAAD | HNRNPA1L2 | exon_skip_107755 | 7.22e+00 | 1.19e-03 | 7.70e+00 | 9.89e-01 | Female-biased |
| PAAD | RBM3 | exon_skip_107755 | 1.13e+01 | 2.94e-03 | 1.17e+01 | 9.96e-01 | Female-biased |
| PAAD | SFPQ | exon_skip_107755 | 7.47e+00 | 3.55e-03 | 7.85e+00 | 9.87e-01 | Female-biased |
| KIRC | PABPC5 | exon_skip_107751 | 7.24e+00 | 9.84e-01 | 6.86e+00 | 3.97e-03 | Male-biased |
| KICH | ELAVL2 | exon_skip_107762 | 6.35e+00 | 3.37e-03 | 6.77e+00 | 9.81e-01 | Female-biased |
| KICH | PABPC5 | exon_skip_107753 | 9.10e+00 | 9.11e-03 | 9.43e+00 | 9.88e-01 | Female-biased |
| KICH | RBM3 | exon_skip_107755 | 1.11e+01 | 1.74e-03 | 1.16e+01 | 9.98e-01 | Female-biased |
| KICH | STAR-PAP | exon_skip_107751 | 1.40e+01 | 1.19e-03 | 1.45e+01 | 9.99e-01 | Female-biased |
| BLCA | PABPC5 | exon_skip_107751 | 6.97e+00 | 8.35e-03 | 7.34e+00 | 9.80e-01 | Female-biased |
| HNSC | PABPC5 | exon_skip_107753 | 9.03e+00 | 9.58e-03 | 9.37e+00 | 9.87e-01 | Female-biased |
SRSF5 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11158345 | chr14:61428327:T:C | - | 0.132853278321603 | 0.000408872070233357 | KIRC | Female-baised eQTL |
| rs12590817 | chr14:61432764:G:A | - | 0.125651538901545 | 0.00412650063560045 | KIRC | Female-baised eQTL |
| rs4902056 | chr14:61427223:G:A | - | -0.107157799788187 | 0.00479719851287595 | KIRC | Female-baised eQTL |
| rs4899044 | chr14:61427245:T:A | - | -0.107157799788187 | 0.00479719851287595 | KIRC | Female-baised eQTL |
| rs8012877 | chr14:61427613:G:T | - | -0.107120410543283 | 0.00488170274088085 | KIRC | Female-baised eQTL |
| rs13379453 | chr14:61425723:A:G | - | -0.105969377271195 | 0.0081162241923445 | KIRC | Female-baised eQTL |
| rs13379462 | chr14:61426049:A:G | - | -0.105969377271195 | 0.0081162241923445 | KIRC | Female-baised eQTL |
| rs1570718 | chr14:61415554:A:T | - | 0.108094638536659 | 0.0172697636354379 | KIRC | Female-baised eQTL |
| rs13379301 | chr14:61426249:T:C | - | -0.101858626418588 | 0.0184585952234087 | KIRC | Female-baised eQTL |
| rs17098351 | chr14:61431862:T:G | - | -0.105500008317475 | 0.0186334713626242 | KIRC | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs79902135 | chr14:79608717:C:T | - | 0.0601434441517097 | 0.0481123885467601 | BLCA | Male-baised eQTL |
| rs727392 | chr14:68535084:G:A | - | -0.105109749668618 | 0.011783003471389 | COAD | Male-baised eQTL |
| rs55705069 | chr14:64780609:C:T | - | 0.109069674699231 | 0.0232938982158059 | COAD | Male-baised eQTL |
| rs75657340 | chr14:65770050:G:A | - | 0.138216435500224 | 0.023319516854298 | COAD | Male-baised eQTL |
| rs2525520 | chr14:68533631:C:T | - | -0.0984873208314171 | 0.0233289615986986 | COAD | Male-baised eQTL |
| rs8012058 | chr14:65763724:C:T | - | 0.137196504080244 | 0.0252459926973649 | COAD | Male-baised eQTL |
| rs36412 | chr14:71889818:A:G | - | 0.0778372195928028 | 0.0266714844987111 | COAD | Male-baised eQTL |
| rs36410 | chr14:71889863:C:A | - | 0.0778372195928028 | 0.0266714844987111 | COAD | Male-baised eQTL |
| rs214004 | chr14:78338968:A:T | - | -0.0606384203303324 | 0.0266982029987867 | COAD | Male-baised eQTL |
| rs12896828 | chr14:78182879:C:T | - | -0.0619264119255444 | 0.0342933184508983 | COAD | Male-baised eQTL |
| rs36411 | chr14:71889834:A:G | - | 0.0737818853834276 | 0.0345435408798311 | COAD | Male-baised eQTL |
| rs11623896 | chr14:78191021:G:T | - | -0.0623310137207752 | 0.0350313623274844 | COAD | Male-baised eQTL |
| rs214005 | chr14:78339830:A:G | - | -0.0611356088454619 | 0.038623098522355 | COAD | Male-baised eQTL |
| rs1957908 | chr14:61393865:A:G | - | -0.152970659839705 | 0.0425421698687186 | COAD | Male-baised eQTL |
| rs8018059 | chr14:78191141:G:A | - | -0.0610266197754766 | 0.0441638158498757 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg14318001 | chr14:69769668 | gene,exon,UTR | -0.157154620686579 | 5.45731054181975e-08 | -0.38018774153812906 | 2.0891714068219274e-11 | BLCA |
| cg12114804 | chr14:69769764 | gene,exon,UTR | -0.164896301634131 | 1.31378579765712e-06 | -0.31679835672349016 | 1.5468986716978456e-08 | BLCA |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of SRSF5 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000100650 | SRSF5 | C0023895 | Liver diseases | 1 | CTD_human |
| ENSG00000100650 | SRSF5 | C0086565 | Liver Dysfunction | 1 | CTD_human |
| ENSG00000100650 | SRSF5 | C0149504 | Encephalopathy, Toxic | 1 | CTD_human |
| ENSG00000100650 | SRSF5 | C0154659 | Toxic Encephalitis | 1 | CTD_human |
| ENSG00000100650 | SRSF5 | C0235032 | Neurotoxicity Syndromes | 1 | CTD_human |